Pharma Stability: Insights, Guidelines, and Expertise
Multinational pharmaceutical companies often market the same product across various regions. However, expiry-related terms may differ in meaning between jurisdictions:
Click to read the full article.
Drugs manufactured in multiple strengths (e.g., 5 mg, 10 mg, 20 mg) or packaging sizes (e.g., blister of 10s, bottle of 100s) may experience differences in degradation rates, packaging barrier properties, or storage stability. Regulatory agencies require shelf life to be scientifically justified for each configuration.
Click to read the full article.
Regulatory authorities such as the USFDA, EMA, ICH, and WHO define and apply these terms differently depending on whether the product is an API, intermediate, or finished dosage form. Using the wrong term—or placing the wrong date on a label—can result in:
Click to read the full article.
Pharmaceutical companies operate in highly regulated environments that vary significantly from one country to another. For instance:
Click to read the full article.
Biologics are protein-based therapeutics derived from living cells, which makes them inherently unstable compared to chemically synthesized drugs. Their degradation can affect not only potency but also structural integrity, potentially leading to:
Click to read the full article.
Shelf life extension may be considered under the following conditions:
Click to read the full article.
Expiration dates directly impact product safety and efficacy. If a product is used beyond its scientifically justified shelf life, it could become ineffective or harmful. Regulatory authorities therefore expect expiry periods to be:
Click to read the full article.
All expiry dates must be supported by scientifically sound stability data, established through validated studies under ICH guidelines. The expiry declared on any pharmaceutical label is legally binding and must:
Click to read the full article.
Internal QA checklists help verify that shelf life is:
Click to read the full article.
Regression analysis helps quantify how a critical quality attribute (CQA) changes over time. Using degradation data collected from real-time or accelerated stability studies, a linear regression line is fitted to determine when the CQA reaches its specification limit. This projected time is considered the product’s shelf life under those storage conditions.
Click to read the full article.